JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3451
Citi Trends
CTRN
$400M
| $4M | ﹤0.01% |
152,422
+149,651
| +5,401% | +$3.15M |
2024 Q1
3 quarters
|
|
3452
Surgery Partners
SGRY
$1.74B
| $4M | ﹤0.01% |
188,966
-470
| -0.2% | -$12.3K |
2016 Q4
32 quarters
|
|
|
CBL
3453
CBL Properties
CBL
$1.69B
| $3.98M | ﹤0.01% |
135,326
+77,673
| +135% | +$2.2M |
2021 Q4
12 quarters
|
|
3454
Energy Recovery
ERII
$346M
| $3.97M | ﹤0.01% |
270,114
-4,779
| -2% | -$81.8K |
2013 Q2
46 quarters
|
|
3455
Caribou Biosciences
CRBU
$131M
| $3.97M | ﹤0.01% |
2,495,922
+2,062,563
| +476% | +$4.15M |
2021 Q3
13 quarters
|
|
3456
iShares Global 100 ETF
IOO
$9.21B
| $3.97M | ﹤0.01% |
39,353
+29,310
| +292% | +$2.94M |
2017 Q2
30 quarters
|
|
3457
Columbia Diversified Fixed Income Allocation ETF
DIAL
$374M
| $3.96M | ﹤0.01% |
225,896
+127
| +0.1% | +$2.28K |
2023 Q3
5 quarters
|
|
3458
PUT
MongoDB
MDB
$28.8B
| $3.96M | ﹤0.01% |
+17,000
| New | +$4.8M |
2024 Q4
0 quarters
|
|
3459
Century Aluminum
CENX
$3.53B
| $3.95M | ﹤0.01% |
217,042
-741,991
| -77% | -$14.6M |
2013 Q2
46 quarters
|
|
3460
Adaptive Biotechnologies
ADPT
$4.52B
| $3.95M | ﹤0.01% |
659,206
-228,627
| -26% | -$1.26M |
2019 Q2
22 quarters
|
|
|
RVNC
3461
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.95M | ﹤0.01% |
1,298,822
+1,164,641
| +868% | +$5.07M |
2014 Q1
43 quarters
|
|
3462
Radiant Logistics
RLGT
$439M
| $3.93M | ﹤0.01% |
587,001
-109,225
| -16% | -$752K |
2017 Q4
28 quarters
|
|
3463
SI-BONE Inc
SIBN
$810M
| $3.93M | ﹤0.01% |
280,453
+102,660
| +58% | +$1.38M |
2018 Q4
24 quarters
|
|
3464
PUT
JetBlue
JBLU
$1.57B
| $3.93M | ﹤0.01% |
+500,000
| New | +$3.39M |
2024 Q4
0 quarters
|
|
3465
Crescent Energy
CRGY
$4.42B
| $3.93M | ﹤0.01% |
268,844
+205,760
| +326% | +$2.79M |
2021 Q4
12 quarters
|
|
3466
B2Gold
BTG
$6.87B
| $3.92M | ﹤0.01% |
1,608,343
+1,090,768
| +211% | +$3.2M |
2013 Q2
46 quarters
|
|
3467
CALL
Reddit
RDDT
$28.4B
| $3.92M | ﹤0.01% |
24,000
-1,000
| -4% | -$123K |
2024 Q3
1 quarter
|
|
3468
N-able
NABL
$799M
| $3.91M | ﹤0.01% |
418,971
+143,065
| +52% | +$1.6M |
2021 Q3
13 quarters
|
|
3469
iShares Core Dividend ETF
DIVB
$1.99B
| $3.91M | ﹤0.01% |
82,421
+16,920
| +26% | +$831K |
2022 Q4
8 quarters
|
|
3470
Bain Capital Specialty
BCSF
$717M
| $3.9M | ﹤0.01% |
222,668
-1,860
| -0.8% | -$31.4K |
2019 Q2
22 quarters
|
|
3471
CALL
AstraZeneca
AZN
$243B
| $3.9M | ﹤0.01% |
29,750
-250
| -0.8% | -$35K |
2023 Q3
5 quarters
|
|
3472
GrafTech
EAF
$246M
| $3.89M | ﹤0.01% |
224,937
-20,946
| -9% | -$390K |
2018 Q2
26 quarters
|
|
3473
PUT
J.M. Smucker
SJM
$12.5B
| $3.89M | ﹤0.01% |
+35,300
| New | +$4.06M |
2024 Q4
0 quarters
|
|
|
KW
3474
DELISTED
Kennedy-Wilson Holdings
KW
| $3.89M | ﹤0.01% |
389,018
+92,736
| +31% | +$1.01M |
2015 Q1
39 quarters
|
|
3475
Xerox
XRX
$397M
| $3.87M | ﹤0.01% |
459,635
-135,518
| -23% | -$1.25M |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.